04:19 AM EDT, 03/27/2026 (MT Newswires) -- Julie Rubinstein, President and Chief Operating Officer, on March 24, 2026, sold 57,180 shares in Adaptive Biotechnologies ( ADPT ) for $802,235. Following the Form 4 filing with the SEC, Rubinstein has control over a total of 468,892 common shares of the company, with 468,892 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1478320/000178066426000016/xslF345X05/form4.xml